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iscussion
r Sahar Gideon (Beer Sheba, Israel). I would like to know
hether you could determine any correlation between intimal
yperplasia and risk factors of these patients?
Dr Burris. We did not look in this particular study at the risk
actors for intimal hyperplasia. We analyzed discarded segments of
hese conduits that were given to us after bypass surgery. The primary
hrust of this study was really to validate OCT’s accuracy and repro-
ucibility as an evaluation tool. However, those are definitely ques-
ions that we are interested in pursuing and will be pursuing in the
uture. We are interested in the pathological significance of these pre-
xisting pathologies and how they relate to patency. I think we have
emonstrated that OCT has the ability to detect these pathologies, which
ill be the first step in understanding their physiological importance.
Dr Gideon. Do you have any information about the ITA?
Dr Burris. Yes. Excellent question. Thank you. It is well known
hat the ITA is the best conduit for bypass surgery. It is typically
arder to get a discarded segment to scan, but on several occasions,
e have observed 4 discarded segments of distal ITA, and in none of
hose samples have we noticed any type of plaque, intimal thickening,
r any other pathology that is detectable with OCT. These findings
uggest the relative health of ITAs and also corroborate our histologic
ndings that there is excellent endothelial integrity and low disease in
he ITA.
Dr Hakob Davtyan (San Bernardino, Calif ). I noticed these
ittle strands of clots in the endoscopically harvested veins in my
ractice, and at this point, I stopped doing endoscopic harvest until
e can figure out how we are going to deal with this. In your
ndings, did it change the way you harvest the vein or just the way
ou practice coronary bypass surgery with saphenous veins?
Dr Burris. Thank you for your excellent question. We did notice
he presence of these clot strands associated with the endoscopic
arvest in RAs and saphenous veins. Thus far, we have only looked
t distal discarded segments of these vessels, and therefore we open
urselves to some sampling error because the distal portions of these
egments are known to have more pre-existent pathology. It seems
easonable to hypothesize that there would also be clot strands in the
ortion of the conduit that is being grafted. However, that is the next
tep for us. We will be doing these scans in situ, in an operative setting
ith sterile probes to determine the heterogeneity and the preva-
ence of these pathologies. We will be looking at plaque as well in the
ore proximal portions of these grafts, which will be grafted. After
e complete that study and we understand the pathology a little bit
ore thoroughly, we will consider revising our protocol. Some have d
26 The Journal of Thoracic and Cardiovascular Surgery ● Febrypothesized that heparinization before endoscopic harvest of the sa-
henous vein could alleviate that, and we will be using OCT to investi-
ate that as a possible solution. I think OCT is a very good modality to
eally have a strong end point to objectively evaluate that problem.
Dr Mustafa Cikirikcioglu (Geneva, Switzerland). How long
as the mean length of the segments that you evaluated?
Dr Burris. The mean length that we evaluated was about 4.5 cm
n veins, and typically, it was a little bit shorter in RAs, about 3 cm,
nd on the rare occasion that we did get an ITA, it was generally less
han a centimeter in length. We only observed 4 of those, though.
Dr Cikirikcioglu. I do not know whether it is soft or rigid, but
f you extend the length of the evaluated segment, what do you
hink about creating new lesions by your device?
Dr Burris. I am sorry, excuse me?
Dr Cikirikcioglu. You evaluated very short segments, but
hat do you think about evaluating longer segments with your
evice? Do you think you can create new lesions with your device
f you will evaluate longer segments?
Dr Weisel. To ask the question another way, the plan here in
he future is to evaluate the entire graft before putting it in. Are you
oing to injure the graft trying to evaluate it?
Dr Burris. Thank you for the question. I am sorry, I did not
nderstand. That was a concern, of course, when we first started this
tudy. We did a cadaver model, actually, at our institution, where we
sed 12 cadavers, and we harvested the RA bilaterally using an
ndoscopic technique. We performed serial scans in which we per-
ormed an initial scan during which we passed the probe into the RA.
e then retracted it and performed another scan just to evaluate
hether there was any intimal injury induced by the insertion of the
robe itself, and we did not notice any detectable intimal injury
ecause of just the insertion of the OCT probe alone.
Dr Paul Kurlansky (Miami, Fla). Just a quick question about
he technology. Is this a technology that will help us visualize
hings in a blood-filled field as a potential alternative or component
o echocardiography just as an imaging technique?
Dr Burris. Excellent question. For anyone who has heard about
CT’s application in coronary arteries, where it is currently underway
n US Food and Drug Administration trials, they might know that the
ne limitation of OCT is that it does not image through blood, unlike
ntravascular ultrasonography. In our particular application, that is an
asily surmountable problem. We exsanguinate the arm with a tour-
iquet before doing these scans and inject a small amount of saline,
ess than 20 mL, to clear the blood from both the vein and the RA, and
his provides us with a bloodless conduit to evaluate with OCT. But
hat is definitely something that we have considered. It is one of the
dvantages of this application over the coronary application, where
ou have to inflate an occlusion balloon in the coronary arteries during
ercutaneous coronary intervention. Therefore I think we have a very
inimally invasive and simple solution to that problem in our appli-
ation, and it has not proved to be a significant factor.
Dr John D. Puskas (Atlanta, Ga). Nicholas, one last question.
here is a wealth of data in peer-reviewed publications demonstrating
hat the short- and intermediate-term patency of grafts harvested by
eans of endoscopic techniques does not differ from the patency of
rafts harvested by using the older open technique. Your data sug-
ested that ought not to be the case. Can you explain this discrepancy?
Dr Burris. Thank you for the question. It certainly has been
ocumented that the patency rate of endoscopic veins is com-
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Burris et al Surgery for Acquired Cardiovascular Diseasearable with that of open-harvested veins. In this particular
tudy, because we did not look at the patency of the evaluated
onduits, we are limited in how we can comment on that
iscrepancy. I defiantly think that OCT has the ability to detect
he important pathologies that have been suspected in thisidterm to late-term failure. v
The Journal of ThoracicMost recently, there was the PREVENT IV trial, which some
eople are familiar with, in which 80% of these veins were harvested
ndoscopically and there was an angiographic 1-year failure rate of
0% for saphenous veins. This is an example of some recent research
hat shows there might still be a problem with endoscopically har-
ested saphenous veins.
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